In8Bio (INAB) Assets (2020 - 2026)
In8Bio's Assets came in at $21.75 million for Q2 2026, up 12.3% from $19.37 million a year earlier but down 17.2% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, In8Bio's Assets was $32.28 million, up 54.1% from FY2024.
- Assets carries a five-year compound annual growth rate of 9.1% (FY2020 to FY2025).
- Going back by year, Assets was $20.94 million in FY2024 (-37.9%), $33.71 million in FY2023 (+2.0%), $33.04 million in FY2022 (-21.8%) and $42.22 million in FY2021 (+101.9%).
- The five-year range for quarterly Assets is $15.97 million (Q3 2024) to $47.13 million (Q3 2021).
- Year-over-year, Assets has increased for four consecutive quarters, with growth averaging 1.8% over the last seven quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 101.9%), and the weakest in Q3 2024 (a decline of 39.1%).
- Business Quant data shows INAB's Assets at $26.27 million (Q1 2026), $32.28 million (Q4 2025) and $16.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 201.13 Bn |
| 10 | In8Bio | 20.44 Mn | -57.91 Mn | - | 21.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.75 Mn |
| Mar 31, 2026 | 26.27 Mn |
| Dec 31, 2025 | 32.28 Mn |
| Sep 30, 2025 | 16.77 Mn |
| Jun 30, 2025 | 19.37 Mn |
| Mar 31, 2025 | 19.87 Mn |
| Dec 31, 2024 | 20.94 Mn |
| Sep 30, 2024 | 15.97 Mn |
| Jun 30, 2024 | 22.50 Mn |
| Dec 31, 2023 | 33.71 Mn |
| Sep 30, 2023 | 26.21 Mn |
| Jun 30, 2023 | 29.72 Mn |
| Mar 31, 2023 | 24.68 Mn |
| Dec 31, 2022 | 33.04 Mn |
| Sep 30, 2022 | 38.38 Mn |
| Jun 30, 2022 | 30.99 Mn |
| Mar 31, 2022 | 36.54 Mn |
| Dec 31, 2021 | 42.22 Mn |
| Sep 30, 2021 | 47.13 Mn |
| Jun 30, 2021 | 17.56 Mn |
API Access
In8Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();